A Phase 3b Study to Assess the Efficacy of Duloxetine 60 mg Once Daily Compared With Placebo on the Reduction of Pain Caused by Osteoarthritis of the Knee, in a 13-week, Double-blind, Randomized Study.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2013
At a glance
- Drugs Duloxetine (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms HMGP
- Sponsors Eli Lilly
- 02 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 Planned end date changed from 1 Jun 2010 to 1 May 2010 as reported by ClinicalTrials.gov.
- 31 Jul 2009 New trial record